CIK 0001628908
- Large accelerated filer
Evolent Health, Inc.
Sign in to watch- Ticker
- EVH
- Exchange
- NYSE
- Industry
- Services-Management Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320454912
- Phone
- +1 571-389-6000
- Business address
- 1812 NORTH MOORE ST, SUITE 1705, ARLINGTON, VA, 22209
- 4 Open-market sale 10% owner sold 2,498,750 shares at $19.53 ($48,800,588)
- 4 Open-market sale 10% owner sold 2,690,961 shares at $19.53 ($52,554,468)
- 4 Open-market sale President sold 15,000 shares at an average $21.19 ($317,896)
- 4 Open-market sale 10% owner sold 2,118,078 shares at $19.53 ($41,366,063)
- 4 Open-market sale Chief Financial Officer sold 7,034 shares at $22.50 ($158,265)
- 4 Open-market sale President sold 15,000 shares at an average $20.87 ($313,008)
- 4 Open-market sale CEO, Valence Health sold 988 shares at $20.20 ($19,958)
- 4 Open-market sale Chief Executive Officer sold 16,300 shares at $20.86 ($340,018)
- 4 Open-market sale President sold 15,000 shares at an average $20.44 ($306,637)
- 4 Open-market sale CEO, Valence Health sold 6,000 shares at $20.11 ($120,660)
- 4 Open-market sale CEO, Valence Health sold 12,000 shares at an average $20.13 ($241,500)
- 4 Open-market sale Chief Executive Officer sold 32,600 shares at an average $20.15 ($656,727)
- 4 Open-market sale President sold 15,000 shares at $19.16 ($287,400)
- 4 Open-market sale 10% owner sold 374,812 shares at $21.54 ($8,073,450)
- 4 Grant or award Chief Executive Officer acquired 61,644 shares (grant or award)
- 4 Grant or award General Counsel acquired 5,479 shares (grant or award)
- 4 Grant or award Principal Accounting Officer acquired 2,740 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 17,123 shares (grant or award)
- 4 Grant or award President acquired 41,096 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 13,699 shares (grant or award)
Page 18 of 22 · 421 filings